GS
AXSM icon

GTS Securities’s Axsome Therapeutics AXSM Stock Holding History

GTS Securities’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,400
Closed -$2.46M – 1517
2024
Q3 		$2.46M Buy
27,400
+4,200
+18% +$367K 0.05% 1421
2024
Q2 		$1.87M Sell
23,200
-13,100
-36% -$970K 0.04% 1552
2024
Q1 		$2.9M Sell
36,300
-39,700
-52% -$3.33M 0.08% 1229
2023
Q4 		$6.05M Buy
76,000
+24,100
+46% +$1.61M 0.13% 879
2023
Q3 		$3.63M Buy
+51,900
New +$3.88M 0.08% 1115

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return